Mar 10, 2026 05:38AM
Mar 10, 2026 05:38AM
Mar 10, 2026 05:38AM
Nov 4, 2025 04:05PM
Jul 20, 2025 08:00PM
Jun 25, 2025 12:43PM
Jun 13, 2025 11:43AM Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'
Apr 29, 2025 04:05PM
Apr 24, 2025 04:09PM
Dec 19, 2024 02:00PM
Nov 8, 2024 04:05PM
Sep 23, 2024 08:03AM
Jun 14, 2024 11:11AM
Apr 30, 2024 04:05PM Gilead Sciences to Present at Upcoming Investor Conferences
Apr 25, 2024 04:11PM
Feb 6, 2024 04:06PM
Jan 22, 2024 12:43PM
Nov 8, 2023 07:13PM
Nov 7, 2023 04:02PM
May 25, 2023 04:05PM
Feb 3, 2023 09:46AM Gilead Sciences shares gain after topping expectations despite lower remdesivir sales
Oct 28, 2022 08:59AM
Oct 25, 2022 07:37AM
Aug 31, 2022 08:42AM
Apr 26, 2022 06:13PM
Mar 7, 2022 09:20AM
Mar 2, 2022 08:12AM
Feb 18, 2022 08:15AM Gilead Sciences (GILD) is Trading Near the Value of the HIV Opportunity, Jefferies Sees Good Risk/Reward
Feb 2, 2022 08:15AM
Feb 1, 2022 05:10PM
Feb 1, 2022 04:31PM
Dec 15, 2021 07:34AM
Oct 28, 2021 04:22PM
May 14, 2021 04:05PM
May 7, 2021 07:48AM Gilead Sciences (GILD) Risk Appears Underestimated After Study Data - Jefferies
Feb 5, 2021 08:23AM
Jan 29, 2021 09:50AM
Jan 14, 2021 08:43AM
Oct 28, 2020 04:07PM
Oct 2, 2020 08:20AM
Sep 14, 2020 11:55AM
Sep 14, 2020 09:30AM Pre-Open Stock Movers 09/14: (IMMU) (SGMS) (NVDA) Higher; (GILD) (MGM) (WMT) Lower (more...)
Sep 14, 2020 07:02AM
Jul 30, 2020 04:30PM
Jul 27, 2020 01:17PM
Jul 21, 2020 06:42AM
Jun 22, 2020 01:47PM
Jun 7, 2020 04:21AM
Jun 3, 2020 12:25PM Gilead's remdesivir could see $7 billion in annual sales on stockpiling boost: analyst
Jun 2, 2020 07:10AM

72,062 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All